Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2020 Aug 8;48(2):383–394. doi: 10.1007/s00259-020-04978-6

Fig. 12.

Fig. 12

Ex vivo validation of EGFR and c-MET expression in HCC827 (a), MDA-MB-468 (b), MDA-MB-231 (c) and MDA-MB-453 (d) tumor sections via IHC. Brown stain represents receptor expression and blue counterstain represents nuclear staining (hematoxylin). Values represent H-scores, which were analyzed by board-certified pathologists